HUT57595A - Process for producing orally administrable pharmaceutical composition having bone strengthening effect - Google Patents

Process for producing orally administrable pharmaceutical composition having bone strengthening effect

Info

Publication number
HUT57595A
HUT57595A HU250790A HU250790A HUT57595A HU T57595 A HUT57595 A HU T57595A HU 250790 A HU250790 A HU 250790A HU 250790 A HU250790 A HU 250790A HU T57595 A HUT57595 A HU T57595A
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
strengthening effect
orally administrable
bone strengthening
administrable pharmaceutical
Prior art date
Application number
HU250790A
Other languages
Hungarian (hu)
Other versions
HU902507D0 (en
HU211084B (en
Inventor
Magdolna Brezo
Zsuzsa Felfoeldy
Judit Frank
Imre Molnar
Laszlo Pavits
Laszlone Pavits
Janos Weltler
Janosne Weltler
Original Assignee
Magdolna Brezo
Zsuzsa Felfoeldy
Judit Frank
Imre Molnar
Laszlo Pavits
Laszlone Pavits
Janos Weltler
Janosne Weltler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magdolna Brezo, Zsuzsa Felfoeldy, Judit Frank, Imre Molnar, Laszlo Pavits, Laszlone Pavits, Janos Weltler, Janosne Weltler filed Critical Magdolna Brezo
Priority to HU250790A priority Critical patent/HU211084B/en
Publication of HU902507D0 publication Critical patent/HU902507D0/en
Publication of HUT57595A publication Critical patent/HUT57595A/en
Publication of HU211084B publication Critical patent/HU211084B/en

Links

Abstract

Orally administered medicinal compsn. for the fortification of bones contains pharmaceutically acceptable cps., namely:-(I) at least one calcium-phosphate, salt. (II) at least one calcium salt formed with an organic acid. Ratio of calcium assay in (I) and (II) should satisfy a 8-1:9-1 wt. ratio. (III) opt. iron: penta-carbonyl additive, (IV) at least one trace element contg. salt, of cobalt, manganese, copper, iron or zinc. Suitable excipients are also used.
HU250790A 1990-04-20 1990-04-20 Process for producing oral pharmaceutical composition of bone strengthening activity HU211084B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU250790A HU211084B (en) 1990-04-20 1990-04-20 Process for producing oral pharmaceutical composition of bone strengthening activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU250790A HU211084B (en) 1990-04-20 1990-04-20 Process for producing oral pharmaceutical composition of bone strengthening activity

Publications (3)

Publication Number Publication Date
HU902507D0 HU902507D0 (en) 1990-08-28
HUT57595A true HUT57595A (en) 1991-12-30
HU211084B HU211084B (en) 1995-10-30

Family

ID=10959747

Family Applications (1)

Application Number Title Priority Date Filing Date
HU250790A HU211084B (en) 1990-04-20 1990-04-20 Process for producing oral pharmaceutical composition of bone strengthening activity

Country Status (1)

Country Link
HU (1) HU211084B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
EP2319518A1 (en) 2002-02-04 2011-05-11 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Use of CO-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
US7968605B2 (en) 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
ES2656237T3 (en) 2011-04-19 2018-02-26 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
JP6134710B2 (en) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． Ruthenium monoxide releasing molecules and uses thereof

Also Published As

Publication number Publication date
HU902507D0 (en) 1990-08-28
HU211084B (en) 1995-10-30

Similar Documents

Publication Publication Date Title
RO116342B1 (en) Oral liquid pharmaceutical composition
CA2272711A1 (en) Method for treating renal failure
MX9504034A (en) Medical administering forms containing tioctic acid, or tioctic acid solid salts having improved release and bioavailability.
BG104476A (en) Therapeutical form for tolterodin with controlled release
IS1858B (en) Method of producing a pharmaceutical composition in the form of pellets for the treatment of intestinal inflammation
NZ221805A (en) Oral, solid, controlled release pharmaceutical dosage form; preparatory processes
UA43342C2 (en) Pharmaceutical composition with the enterosoluble coating for the oral administration, method of obtaining thereof, method for inhibition secretion of acid by stomach in mammals and human, method of treating the diseases in mammals and human, associated with the secretion of acid with the stomach
GR3018009T3 (en) Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism, and the compositions obtained.
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
MXPA02012064A (en) Macromolecular drug complexes and compositions containing the same.
HUT57595A (en) Process for producing orally administrable pharmaceutical composition having bone strengthening effect
IL87452A0 (en) Calcium supplements
GB8916734D0 (en) Pharmaceutical and dietary uses of fatty acids
SE8701077D0 (en) PHARMACEUTICAL COMPOSITION
EP0429157B1 (en) Dietary supplementation with potassium magnesium citrate
ES2042831T3 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OSTEOPOROSIS.
EG17992A (en) Preparation of a medicament for arthritis and theumatism
HUT73500A (en) Use of benzydamine for producing pharmaceutical compositions for treatment of pathological conditions caused by tnf
ZA892023B (en) Orally administered pharmaceutical agent for iron and magnesium substitutive therapy
GB8719670D0 (en) Pharmaceutical compositions
IE38235L (en) Combatting swine dysentery
RU95115404A (en) APPLICATION OF RILUZOLE AS A MEANS FOR THE TREATMENT OF PARKINSON'S DISEASE AND PARKINSON'S SYNDROMES, METHOD FOR PRODUCING A MEDICINE
MX9704105A (en) Kit for osteoporosis treatment cycle.
TH32072A (en) Methods for the prevention and treatment of stomach and intestinal disorders.
IT1152291B (en) Synthetic vitamin=D glycoside(s)

Legal Events

Date Code Title Description
DFD9 Temporary prot. cancelled due to non-payment of fee
HMM4 Cancellation of final prot. due to non-payment of fee